Interleukin-18, From Neuroinflammation to Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|38|4213-4224

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.38, 2010-12, pp. : 4213-4224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer’s Disease

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 8, 2016-03 ,pp. : 849-857

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotection by Association of Palmitoylethanolamide with Luteolin in Experimental Alzheimer’s Disease Models: The Control of Neuroinflammation

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 9, 2014-11 ,pp. : 1530-1541

Bentham Science Publishers

Access to resources Recommend Favorite

Reactive Oxygen Species, Redox Signaling and Neuroinflammation in Alzheimer's Disease: The NF-&kgr;B Connection

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 5, 2015-03 ,pp. : 446-457

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of 7 Nicotinic Acetylcholine Receptors and 7-Specific Antibodies in Neuroinflammation Related to Alzheimer Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2035-2049

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines in Neuroinflammation and Alzheimer's Disease

By  

Current Drug Targets, Vol. 5, Iss. 6, 2004-08 ,pp. : 529-534

Bentham Science Publishers

Access to resources Recommend Favorite